Inspire Medical Systems, Inc. (NYSE:INSP - Get Free Report) CEO Timothy P. Herbert sold 40,000 shares of the company's stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $205.09, for a total value of $8,203,600.00. Following the completion of the transaction, the chief executive officer now owns 63,658 shares in the company, valued at approximately $13,055,619.22. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Inspire Medical Systems Stock Up 2.5 %
Inspire Medical Systems stock opened at $210.19 on Thursday. Inspire Medical Systems, Inc. has a one year low of $123.27 and a one year high of $330.00. The business has a fifty day moving average price of $198.99 and a 200-day moving average price of $180.96.
Inspire Medical Systems (NYSE:INSP - Get Free Report) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.53. The company had revenue of $192.51 million during the quarter, compared to analyst estimates of $186.75 million. Inspire Medical Systems had a negative return on equity of 3.93% and a negative net margin of 3.39%. The firm's quarterly revenue was up 39.6% on a year-over-year basis. During the same quarter last year, the company earned $0.10 earnings per share. On average, research analysts predict that Inspire Medical Systems, Inc. will post -0.35 EPS for the current fiscal year.
Institutional Investors Weigh In On Inspire Medical Systems
4 Cryptos BETTER than Bitcoin
From True Market Insiders | Ad
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
Click For My #1 FREE Crypto for 2024
Large investors have recently added to or reduced their stakes in the business. Wellington Management Group LLP boosted its stake in Inspire Medical Systems by 72.8% during the third quarter. Wellington Management Group LLP now owns 976,972 shares of the company's stock valued at $193,870,000 after buying an additional 411,480 shares during the period. OPTIMAS CAPITAL Ltd bought a new stake in Inspire Medical Systems during the fourth quarter valued at $3,861,000. Seven Eight Capital LP bought a new stake in Inspire Medical Systems during the third quarter valued at $1,558,000. Charles Schwab Investment Management Inc. boosted its stake in Inspire Medical Systems by 3.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 256,222 shares of the company's stock valued at $50,845,000 after buying an additional 7,838 shares during the period. Finally, Canada Pension Plan Investment Board raised its position in Inspire Medical Systems by 29.7% during the third quarter. Canada Pension Plan Investment Board now owns 40,200 shares of the company's stock valued at $7,977,000 after purchasing an additional 9,200 shares in the last quarter. Institutional investors own 94.91% of the company's stock.
Analyst Ratings Changes
Several research firms recently commented on INSP. Stifel Nicolaus reiterated a "hold" rating and issued a $210.00 price objective on shares of Inspire Medical Systems in a research note on Tuesday, January 2nd. Truist Financial reiterated a "buy" rating and issued a $280.00 price objective on shares of Inspire Medical Systems in a research note on Wednesday, March 20th. Morgan Stanley began coverage on Inspire Medical Systems in a research note on Tuesday, March 19th. They issued an "overweight" rating and a $250.00 price objective on the stock. KeyCorp initiated coverage on Inspire Medical Systems in a research note on Tuesday, February 6th. They issued an "overweight" rating and a $278.00 price objective on the stock. Finally, Jefferies Financial Group began coverage on Inspire Medical Systems in a research report on Friday, January 19th. They set a "buy" rating and a $245.00 target price on the stock. Four research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. According to MarketBeat.com, Inspire Medical Systems has an average rating of "Moderate Buy" and an average target price of $271.29.
Check Out Our Latest Analysis on INSP
Inspire Medical Systems Company Profile
(
Get Free Report)
Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
